REVMATOID ARTRIT: PATOGENEZ, DIAGNOSTIKA VA ZAMONAVIY DAVOLASH YONDASHUVLARI
Keywords:
revmatoid artrit, autoimmun kasallik, sinovit, pannus, DMARDs, biologik preparatlar, remissiya, yallig’lanishAbstract
Revmatoid artrit (RA) — immunologik buzilishlar asosida rivojlanadigan, bo‘g’imlarning progressiv shikastlanishi va tizimli asoratlar bilan kechadigan surunkali yallig’lanish kasalligidir. Ushbu maqolada RAning etiologiyasi, patogenetik mexanizmlari, klinik ko‘rinishi, zamonaviy diagnostika mezonlari va davolash strategiyalari ilmiy manbalar asosida keng yoritilgan. Erta tashxis va maqsadga yo‘naltirilgan davolashning kasallik prognozini tubdan yaxshilashi ko‘rsatilgan.
References
Smolen J.S. et al. Rheumatoid arthritis. Nature Reviews Disease Primers, 2018; 4:18001.
World Health Organization. Chronic Rheumatic Conditions. Geneva: WHO, 2022.
Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. New England Journal of Medicine, 1978; 298(16):869–871.
Klareskog L. et al. A new model for an etiology of rheumatoid arthritis. Arthritis & Rheumatism, 2006; 54(1):38–46.
McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine, 2011; 365(23):2205–2219.
Young A., Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 2007; 21(5):907–927.
Aletaha D. et al. 2010 Rheumatoid arthritis classification criteria. Arthritis & Rheumatism, 2010; 62(9):2569–2581.
Smolen J.S. et al. EULAR recommendations for treat-to-target in RA. Annals of the Rheumatic Diseases, 2020; 79(6):685–699.
Burmester G.R., Pope J.E. Novel treatment strategies in rheumatoid arthritis. Lancet, 2017; 389(10086):2338–2348.





